Boel, AnneLopez-Medina, Clementinavan der Heijde, Desiree M F Mvan Gaalen, Floris Alexander2023-05-032023-05-032021-06-14Boel A, López-Medina C, van der Heijde DMFM, van Gaalen FA. Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study. Rheumatology (Oxford). 2022 Apr 11;61(4):1468-1475http://hdl.handle.net/10668/19829Age at onset is useful in identifying chronic back patients at an increased risk of axial SpA (axSpA). However, the majority of data on which the criterion of age at onset Analyses were applied to patients from 24 countries across the world with an axSpA diagnosis and known age at onset of axial complaints. Cumulative probability plots were used to display the cumulative distribution of age at onset of axial symptoms. Linear regression models were built to assess the effect of HLA-B27 and gender on age at onset of axial symptoms. Of 2579 axSpA patients, 92% had an age at onset of axial symptoms Around the world, the great majority of axSpA patients had an age at onset of axial disease of <45 years, with HLA-B27 and male gender associated with earlier disease onset.enAttribution-NonCommercial 4.0 Internationalhttp://creativecommons.org/licenses/by-nc/4.0/HLA-B27Age at onsetAxial spondyloarthritisGenderAdultAge of onsetAxial spondyloarthritisHLA-B27 antigenHumansMaleMiddle eastSpondylarthritisYoung adultresearch article34260699open accessAntígeno HLA-B27Edad de inicioEspondiloartritisEspondiloartritis axialMedio oriente10.1093/rheumatology/keab5441462-0332PMC8996784https://academic.oup.com/rheumatology/article-pdf/61/4/1468/43355925/keab544.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996784/pdf